Plain English Breakdown
The bill does not specify the exact details of how contributions or no-cost care will be adopted by rule, leaving some uncertainty in implementation specifics.
Experimental Treatment Access Trust Fund
This bill creates a trust fund to assist eligible patients with costs related to travel for experimental treatments, funded by contributions from licensed treatment centers.
What This Bill Does
- Creates the Experimental Treatment Access Trust Fund within the Department of Health.
- Allows licensed experimental treatment centers to contribute up to 2% of their net annual profits from experimental treatments to this fund.
- Licensed experimental treatment centers can provide care at no cost instead of contributing money.
- Sets a termination date for the trust fund on July 1, 2030, unless it is reviewed and extended earlier.
Who It Names or Affects
- Eligible patients with terminal conditions or rare diseases who need experimental treatments.
- Licensed experimental treatment centers that can contribute to the trust fund or provide care at no cost.
Terms To Know
- Experimental Treatment Access Trust Fund
- A special fund created by the state to help people with terminal conditions or rare diseases pay for travel and costs related to experimental treatments.
- Licensed Experimental Treatment Centers
- Medical facilities that are allowed by law to provide new, unproven medical treatments to patients.
Limits and Unknowns
- The bill only takes effect if another piece of legislation (HB 1381) is also passed in the same session.
- It does not specify how much money will be available or what specific costs it covers for eligible patients.